Boston Financial Mangement LLC Novartis Ag Transaction History

Boston Financial Mangement LLC

$3.18 Billion
Q4 2024

A detailed history of Boston Financial Mangement LLC transactions in Novartis Ag stock. As of the latest transaction made, Boston Financial Mangement LLC holds 9,072 shares of NVS stock, worth $1.01 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,072

Previous 8,045 12.77%

Holding current value

$1.01 Million

Previous $925,000 4.65%

% of portfolio

0.03%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$96.78 - $117.18 $99,393 - $120,343	1,027 Added 12.77%	9,072 $882,000
Q3 2024 Oct 24, 2024	SELL	$106.13 - $120.89 $127,674 - $145,430	-1,203 Reduced 13.01%	8,045 $925,000
Q2 2024 Jul 29, 2024	BUY	$92.57 - $107.37 $66,187 - $76,769	715 Added 8.38%	9,248 $984,000
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $73,834 - $84,064	-775 Reduced 8.33%	8,533 $825,000
Q4 2023 Feb 12, 2024	BUY	$92.27 - $101.54 $77,783 - $85,598	843 Added 9.96%	9,308 $939,000
Q3 2023 Nov 09, 2023	BUY	$94.73 - $105.13 $32,397 - $35,954	342 Added 4.21%	8,465 $862,000
Q2 2023 Aug 07, 2023	BUY	$92.52 - $104.91 $423,556 - $480,277	4,578 Added 129.14%	8,123 $819,000
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $14,245 - $16,520	178 Added 5.29%	3,545 $326,000
Q4 2022 Jan 27, 2023	BUY	$75.55 - $92.52 $28,331 - $34,695	375 Added 12.53%	3,367 $0
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $298 - $349	-4 Reduced 0.13%	2,992 $227,000
Q2 2022 Aug 08, 2022	BUY	$80.52 - $93.75 $644 - $750	8 Added 0.27%	2,996 $253,000
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $239,368 - $270,772	2,988 New	2,988 $262,000
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $264,695 - $312,149	-3,170 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $65,188 - $78,849	-835 Reduced 20.85%	3,170 $299,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $16,428 - $18,200	-200 Reduced 4.76%	4,005 $348,000
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $40,950 - $46,096	-506 Reduced 10.74%	4,205 $367,000
Q1 2020 May 05, 2020	SELL	$70.67 - $99.01 $66,288 - $92,871	-938 Reduced 16.6%	4,711 $388,000
Q4 2019 Feb 05, 2020	SELL	$84.35 - $95.37 $16,870 - $19,074	-200 Reduced 3.42%	5,649 $535,000
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $55,601 - $61,269	-650 Reduced 10.0%	5,849 $508,000
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $22,620 - $27,840	-300 Reduced 4.41%	6,499 $593,000
Q1 2019 Apr 25, 2019	SELL	$75.32 - $86.15 $45,191 - $51,690	-600 Reduced 8.11%	6,799 $654,000
Q4 2018 Jan 31, 2019	SELL	$73.66 - $82.02 $52,003 - $57,906	-706 Reduced 8.71%	7,399 $635,000
Q3 2018 Nov 02, 2018	BUY	$66.94 - $77.43 $95,389 - $110,337	1,425 Added 21.33%	8,105 $698,000
Q2 2018 Aug 03, 2018	SELL	$64.91 - $73.36 $194,730 - $220,080	-3,000 Reduced 30.99%	6,680 $505,000
Q4 2017 Feb 05, 2018	SELL	$72.33 - $77.64 $12,657 - $13,587	-175 Reduced 1.78%	9,680 $813,000
Q3 2017 Oct 30, 2017	BUY	$74.14 - $77.27 $730,649 - $761,495	9,855	9,855 $846,000

Others Institutions Holding NVS

# of Institutions

1,492

Shares Held

130M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.

Account

Boston Financial Mangement LLC Novartis Ag Transaction History